Health supplement MororiX is ideal for pre-diabetics and help against the progress to Type-2 diabetes.

 

Specialty nutraceutical company Entity Health Ltd has launched a natural health supplement called MomoriX to support normal glucose levels.

Globally, the incidence of diabetes has increased at an alarming rate in recent decades. In Singapore, the number of people with diabetes is expected to rise from 440,000 in 2014 to one million by 2050, with projected healthcare costs from diabetes expected to rise beyond S$940 million in 2014 to S$1.8 billion in 2050. About one in seven people in Singapore have pre-diabetes. Without intervention, at least 35 percent of those with pre-diabetes will progress to Type-2 diabetes within eight years.

In response to this major public health issue, the Diabetes Prevention and Care Taskforce was formed in 2016 by the Ministry of Health and the Health Promotion Board with a key strategic shift toward prevention, early detection and intervention during the pre-diabetes stage. Singaporeans are encouraged to screen for pre-diabetes as this is a warning sign for diabetes.

Those with pre-diabetes have a higher blood sugar level than normal and are unable to process sugar (glucose) properly. As a result, sugar accumulates in the bloodstream instead of its normal job of fueling the cells that make up muscles and other tissues.

Entity Health’s MomoriX can be used by those who are concerned about their blood sugar levels and is able to be taken as part of the defence against pre-diabetes progressing into Type-2 diabetes. Together with a strategy of maintaining a healthy weight, adopting a healthy diet and regular physical activity, people with pre-diabetes can reduce their risk of developing diabetes. The supplement can also help those already suffering from Type-2 diabetes when used as an adjunct to anti-diabetic medication.

MomoriX is formulated with natural plant-based active ingredients including Momordica Charantia (Momordica) and Gymnema Sylvestre (Gymnema), both indigenous medicinal plants to Asia, South America, India and East Africa that have traditionally been used in the treatment of Type 2 diabetes. Clinical studies have shown that these ingredients promote a hypoglycaemic effect through the uptake of glucose from the bloodstream, thereby enabling improved glucose control. While both ingredients harness the ability to stimulate insulin release, Gymnema has also been found to promote the regeneration of islet cells in the pancreas, leading to improved insulin secretion.

MomoriX also has Cursol, a patented formulation of curcumin that is 300 times better absorbed than normal curcumin. Curcumin, the major constituent of turmeric, possesses strong anti-oxidant and anti-inflammatory properties. Studies have also shown that curcumin reduces post-meal glycaemic response and insulin demand in healthy individuals. The recommended serving size per day is one to two capsules twice a day with meals or as recommended by the patient’s physician.

 

MomoriX with 60 capsules is available at Entity Health’s online store for S$39.


 

---